GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Medicus Sciences Acquisition Corp (NAS:MSAC) » Definitions » Cash Flow from Financing

Medicus Sciences Acquisition (Medicus Sciences Acquisition) Cash Flow from Financing : $0.00 Mil (TTM As of Sep. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Medicus Sciences Acquisition Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Sep. 2022, Medicus Sciences Acquisition paid $0.00 Mil more to buy back shares than it received from issuing new shares. It received $0.00 Mil from issuing more debt. It paid $0.00 Mil more to buy back preferred shares than it received from issuing preferred shares. It received $0.00 Mil from paying cash dividends to shareholders. It received $0.00 Mil on other financial activities. In all, Medicus Sciences Acquisition spent $0.00 Mil on financial activities for the three months ended in Sep. 2022.


Medicus Sciences Acquisition Cash Flow from Financing Historical Data

The historical data trend for Medicus Sciences Acquisition's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicus Sciences Acquisition Cash Flow from Financing Chart

Medicus Sciences Acquisition Annual Data
Trend Dec20 Dec21
Cash Flow from Financing
- 94.23

Medicus Sciences Acquisition Quarterly Data
Nov20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Cash Flow from Financing Get a 7-Day Free Trial - - - - -

Medicus Sciences Acquisition Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Medicus Sciences Acquisition's Cash from Financing for the fiscal year that ended in Dec. 2021 is calculated as:

Medicus Sciences Acquisition's Cash from Financing for the quarter that ended in Sep. 2022 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medicus Sciences Acquisition  (NAS:MSAC) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Medicus Sciences Acquisition's issuance of stock for the three months ended in Sep. 2022 was $0.00 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Medicus Sciences Acquisition's repurchase of stock for the three months ended in Sep. 2022 was $0.00 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Medicus Sciences Acquisition's net issuance of debt for the three months ended in Sep. 2022 was $0.00 Mil. Medicus Sciences Acquisition received $0.00 Mil from issuing more debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Medicus Sciences Acquisition's net issuance of preferred for the three months ended in Sep. 2022 was $0.00 Mil. Medicus Sciences Acquisition paid $0.00 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Medicus Sciences Acquisition's cash flow for dividends for the three months ended in Sep. 2022 was $0.00 Mil. Medicus Sciences Acquisition received $0.00 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Medicus Sciences Acquisition's other financing for the three months ended in Sep. 2022 was $0.00 Mil. Medicus Sciences Acquisition received $0.00 Mil on other financial activities.


Medicus Sciences Acquisition Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Medicus Sciences Acquisition's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Medicus Sciences Acquisition (Medicus Sciences Acquisition) Business Description

Traded in Other Exchanges
N/A
Address
152 West 57th Street, Floor 20, New York, NY, USA, 10019
Medicus Sciences Acquisition Corp is a blank check company.
Executives
Eric Cheng officer: Chief Business Officer 152 WEST 57TH STREET, FLOOR 20, NEW YORK NY 10019
Kenneth Berkovitz director 152 WEST 57TH STREET, FLOOR 20, NEW YORK NY 10019
Christopher Kaster director 152 WEST 57TH STREET, FLOOR 20, NEW YORK NY 10019
Ross Levine director 152 WEST 57TH STREET, FLOOR 20, NEW YORK NY 10019
Judah Drillick officer: Chief Financial Officer 152 WEST 57TH STREET, FLOOR 20, NEW YORK NY 10019
Jacob Gottlieb director, 10 percent owner, officer: Executive Chairman 152 WEST 57TH STREET, FLOOR 20, NEW YORK NY 10019
Medicus Sciences Holdings Llc 10 percent owner 152 WEST 57TH STREET, FLOOR 20, NEW YORK NY 10019
Michael Castor director, 10 percent owner, officer: Chief Executive Officer 152 WEST 57TH STREET, FLOOR 20, NEW YORK NY 10019

Medicus Sciences Acquisition (Medicus Sciences Acquisition) Headlines